Avalon Investment & Advisory’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | $18M | Buy |
|
|||||
|
2022
Q4 | $14.4M | Buy |
|
|||||
|
2022
Q3 | $10.6M | Sell |
|
|||||
|
2022
Q2 | $12.2M | Sell |
|
|||||
|
2022
Q1 | $12.7M | Buy |
|
|||||
|
2021
Q4 | $7.59M | Sell |
|
|||||
|
2021
Q3 | $9.05M | Buy |
|
|||||
|
2021
Q2 | $7.41M | Buy |
|
|||||
|
2021
Q1 | $4.71M | Sell |
|
|||||
|
2020
Q4 | $29.3M | Buy |
|
|||||
|
2020
Q3 | $29.1M | Sell |
|
|||||
|
2020
Q2 | $27.5M | Sell |
|
|||||
|
2020
Q1 | $26M | Buy |
|
|||||
|
2019
Q4 | $24.5M | Sell |
|
|||||
|
2019
Q3 | $21.9M | Buy |
|
|||||
|
2019
Q2 | $21.5M | Sell |
|
|||||
|
2019
Q1 | $22.1M | Sell |
|
|||||
|
2018
Q4 | $19.5M | Buy |
|
|||||
|
2018
Q3 | $3.35M | Buy |
|
|||||
|
2018
Q2 | $2.27M | Buy |
|
|||||
|
2018
Q1 | $2.41M | Buy |
|
|||||
|
2017
Q4 | $1.21M | Buy |
|
|||||
|
2017
Q3 | $1.01M | Buy |
|
|||||
|
2017
Q2 | $535K | Sell |
|
|||||
|
2017
Q1 | $462K | Buy |
|
|||||
|
2016
Q4 | – | Sell |
|
|||||
|
2016
Q3 | $1.07M | Sell |
|
|||||
|
2016
Q2 | $1.47M | Buy |
|
|||||
|
2016
Q1 | $824K | Buy |
|
|||||
|
2015
Q4 | $717K | Buy |
|
|||||
|
2013
Q4 | – | Sell |
|
|||||
|
2013
Q3 | $378K | Buy |
|
|||||
|
2013
Q2 | $345K | Buy |
|